Furthermore, our previous research has confirmed the association of Lp(a) levels ≥ 30 mg/dL with the development and progression of carotid and coronary artery atherosclerosis [13], as well as with early-onset CAD, providing additional rationale for the selection of this cut-off value. The gene discussed is LPA; the disease is coronary artery disorder.